Drug Discovery

Can AI and Pharma Unite in a $6 Billion Breakthrough?
Research & Development Can AI and Pharma Unite in a $6 Billion Breakthrough?

The pharmaceutical industry finds itself at a historic crossroads, where the fusion of cutting-edge technology and medical science could redefine the future of drug discovery, promising faster and more efficient solutions. A monumental $6 billion partnership between XtalPi, a Chinese company

Roche’s Evrysdi Tablets Approved for SMA Treatment in UK
Management & Regulatory Roche’s Evrysdi Tablets Approved for SMA Treatment in UK

Imagine a world where a rare, life-altering condition like spinal muscular atrophy (SMA), affecting roughly one in 10,000 newborns globally, can be managed with a simple tablet that doesn’t require refrigeration. This scenario is now a reality for many in the UK with the recent approval of Roche’s

Why Did Lilly's Obesity Pill Trial Disappoint Investors?
Research & Development Why Did Lilly's Obesity Pill Trial Disappoint Investors?

I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, as well as a deep understanding of technology and innovation in the pharmaceutical industry. Today, we’re diving into the latest developments surrounding obesity and

China’s Rise as a Global Leader in AI Drug Discovery
Research & Development China’s Rise as a Global Leader in AI Drug Discovery

In a world where the race to develop life-saving drugs is more competitive than ever, China has emerged as an unexpected frontrunner, leveraging artificial intelligence (AI) to transform the pharmaceutical industry and challenge long-standing global dynamics. Once primarily recognized for

Trend Analysis: Flavonols in Drug Resistance Solutions
Research & Development Trend Analysis: Flavonols in Drug Resistance Solutions

In an era where medical advancements are constantly tested by evolving health challenges, drug resistance stands as a formidable barrier, impacting millions of patients worldwide with a staggering failure rate in treatments like chemotherapy, where up to 50% of cases show reduced efficacy due to

AstraZeneca's STRIDE Regimen Revolutionizes Liver Cancer Care
Management & Regulatory AstraZeneca's STRIDE Regimen Revolutionizes Liver Cancer Care

I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, as well as a deep understanding of technological innovation in the industry. Today, we’re diving into the groundbreaking news about AstraZeneca’s Imfinzi and Imjudo

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later